Pain Processing In Relation To Breathing

NCT ID: NCT06169917

Last Updated: 2023-12-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-14

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to investigate the effect of breathing on the processing of experimental pain in healthy participants. The main questions are:

1. Does breathing rate influence the spatial extent of thermally induced secondary hyperalgesia, a proxy of central sensitization?
2. Does resonance frequency breathing influence the autonomic nervous system, compared to baseline and compared to paced breathing at a natural frequency?
3. Is spinal excitability, measured using the magnitude of the nociception withdrawal reflex (NWR), affected by resonance frequency breathing, compared to paced breathing at a natural frequency?

Participants:

* will receive heat stimuli
* 's skin's sensitivity will be tested using quantitative sensory testing tools.
* will receive various instructions on the speed of their breathing
* 's heart rate, respiratory rate and sweat response will be measured
* will fill in questionnaires

Researchers will compare the spatial extent of sensitivity resulting from application of heat stimuli during paced resonance frequency breathing compared to paced breathing at a natural frequency to see if the breathing rhythm influences central sensitization processes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Sensitisation Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy participants

Participants should be aged 18-40, in good health, capable of informed consent, without major medical/psychiatric conditions (e.g., heart disease, diabetes, autoimmune disorders, infectious diseases, major depressive disorder), chronic pain, respiratory issues, or ongoing acute pain, qualify. Exclusions: inability to follow instructions (e.g., language issues), recent alcohol/drug/analgesic use (\<24h), caffeine intake (\>100mg \<8h), or scar tissue/general reduced sensitivity in test areas.

Participants undergo three interventions. The heat stimulation intervention is performed twice. During one heat stimulation intervention, participants receive the 'resonance frequency breathing' intervention. During the other heat stimulation intervention, participants receive the 'natural frequency breathing' intervention. The order of the breathing interventions is counterbalanced across participants.

Group Type EXPERIMENTAL

Paced Resonance Frequency Breathing

Intervention Type BEHAVIORAL

Participants are required to pace their breathing to their pre-determined individual resonance frequency.

Paced Breathing at Natural Frequency

Intervention Type BEHAVIORAL

Participants are required to pace their breathing to their pre-determined individual breathing frequency at rest.

Heat Stimulations

Intervention Type OTHER

Participants will undergo a heat stimulation procedure on their left and right foot (the order of which is counterbalanced across participants). During this procedure, there are 10 blocks, with an inter-stimulus interval of 30 seconds between two blocks. During a block, six 6-second heat stimulations (48 degrees) are given. Between the stimulations, the temperature quickly returns to baseline (32 degrees).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paced Resonance Frequency Breathing

Participants are required to pace their breathing to their pre-determined individual resonance frequency.

Intervention Type BEHAVIORAL

Paced Breathing at Natural Frequency

Participants are required to pace their breathing to their pre-determined individual breathing frequency at rest.

Intervention Type BEHAVIORAL

Heat Stimulations

Participants will undergo a heat stimulation procedure on their left and right foot (the order of which is counterbalanced across participants). During this procedure, there are 10 blocks, with an inter-stimulus interval of 30 seconds between two blocks. During a block, six 6-second heat stimulations (48 degrees) are given. Between the stimulations, the temperature quickly returns to baseline (32 degrees).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. over 18 and below 40 years of age
2. good general health
3. able to give informed consent

Exclusion Criteria

1. any major medical or psychiatric condition (e.g. heart disease, diabetes, autoimmune disorders, infectious diseases, major depressive disorder), any chronic pain condition, any respiratory problems, any current acute pain at time of study
2. inability to follow study instructions, e.g. due to language problems
3. Consumption of alcohol, drugs, analgesics within the last 24 h
4. Consumption of no more than 100 mg of caffeine within the last 8 h
5. Scar tissue or generally reduced sensitivity in the designated testing site areas


1. Shoe size \< 38
2. Restless-Legs-Syndrome
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Balgrist University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Schweinhardt Petra

Prof. Dr. med

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Balgrist, University Zürich

Zurich, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Petra Schweinhardt, Prof. Dr. med

Role: CONTACT

Phone: +41 44 510 73 81

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Petra Schweinhardt, Prof. Dr. med

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-00518

Identifier Type: -

Identifier Source: org_study_id